Search results

The work of the group comprises Radioactivity Measurement Standards, Radioanalytical chemistry, Environmental Radioactivity Measurement Centre, Nuclear security science and Environmental monitoring.

The ANSTO Science Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.

With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.

Detailed data on ANSTO electricity use and CO2 emissions for FY2024 - FY2025

Lutetium-177 used for advanced prostate cancer

ANSTO operates a range of cobalt-60 gamma irradiators, providing the Australian community with a range of irradiation services for medical, health, industry, agriculture and research purposes.

ANSTO is dedicated to identifying opportunities for the application of knowledge and technology developed by the organisation for a wide range of industry applications.

Australia and Sri Lanks signs new partnership to fight chronic kidney disease.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.

This scholarship recognises outstanding ability and promise in the field of nuclear science and technology, specifically as it applies to nuclear energy. Successful applicants will demonstrate a history of interest in nuclear energy and a desire to continue this interest.

ANSTO has agreed to participate in an Australian trial of a review of research infrastructure access proposals in which applicants remain anonymous to aid the removal of structural barriers to the career progression of Women in STEM.

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

The role of trace elements as palaeoclimate proxies has been explored in ANSTO-led collaborative environmental research.

ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.